
|Articles|November 1, 2022
Origins Insights Announces Transition to Patient Specialist Agency
Deeper focus on patient engagement across the pharma/biotech product lifecycle.
Advertisement
Origins Insights, a Resonant Group company, announced the evolution of its service offering to become an exclusively patient focused agency.
Origins evolved service offering is built around a four-step process moving through strategy development, insight generation, patient experience data collation, and solutions designed to optimize the patient voice.
Read more about the transition
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $ 2.3 Billion Agreement to Acquire Ajax Therapeutics
2
FDA Awards Priority Voucher to Compass for Psychedelic Therapy in Treatment-Resistant Depression
3
Moving Cell and Gene Therapy Towards the Future: Q&A with Maher Masoud
4
Regeneron Agrees to Lower Drug Costs for U.S. Patients and Provide Otarmeni for Free
5




